Follow cash merger, going-private and tender-offer disclosures for US-listed companies. Review original terms and filing milestones; historical documents are not broadcast as new events.
Times are US Eastern. Terms reflect each document; filing does not establish approval or completion. Liquidations, spin-offs and stock-swap valuations are not yet covered.
Recorded cases：8Last checked：10/11/2026, 7:10:48 PM EDTCheck latest documents for price, conditions and validity; spreads and annualized returns are not shown.
ely, the “excluded shares”)), outstanding immediately prior to the effective time will be cancelled and converted into the right to receive $123.00 per share in cash, without interest (the “Merger Consideration”). Synaptics’ board of directors (the “Synaptics board”) has unanimously approved the Merger Agreement and recommend
Agreement and Plan of Merger, dated as of October 1, 2026
nt ”), to purchase all outstanding shares of common stock, par value $0.001 per share (“ Shares ”), of the Company, at a price per Share of $10.50 per Share, net to the seller in cash, without interest, subject to any withholding tax (the “ Offer Price ”), upon the terms and subject to the conditions described in the Offer t
nt ”), to purchase all outstanding shares of common stock, par value $0.001 per share (“ Shares ”), of the Company, at a price per Share of $10.50 per Share, net to the seller in cash, without interest, subject to any withholding tax (the “ Offer Price ”), upon the terms and subject to the conditions described in the Offer t
Offer has been extended until 5:00 p.m., Eastern Time, on October 7, 2026
(“ Copart ”), to purchase all outstanding shares of common stock, par value $0.001 per share (“ Shares ”), of ACV, at a price per Share of $10.50 per Share, net to the seller in cash, without interest, subject to any withholding tax (the “ Offer Price ”), upon the terms and subject to the conditions described in the Offer t
34 MEDTRONIC PLC (Name of Subject Company (Issuer) and Filing Person (Offeror)) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G5960L103 (CUSIP Number of Class of Securities) Brian Sandstrom, Esq. Assistant Secretary c/o Medtronic, Inc. 710 Medtronic Parkway Minneapolis, Minnesota 5543
es, or such lesser number of shares as are validly tendered and not withdrawn, of its Common Stock, par value $.01 per share, at a price of $75.00 per Share, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 24, 2026 the "Offer to Purchase"), and in the related Letter of Transmit
Offer to Purchase dated September 24, 2026
Amendment filed
Cash offer per share in document (USD)
Unverified / no unambiguous cash price
Expiration date cited in document
Unverified
Proration is disclosed; not all tendered shares may be accepted.
14, 2026, the last full Nasdaq trading day prior to announcement of the Offer, the closing per Share sales price as reported by Nasdaq was $70.67 per Share. Stockholders are urged to obtain current market quotations for the shares. See Section 7. The Board of Directors of the Company has approved the Offer. However, neither
ucts, Inc. is offering to purchase your shares of UTMD common stock. IF I TENDER MY SHARES, WHAT WILL THE PURCHASE PRICE FOR THE SHARES BE? $75.00 per share, net to you, without any brokerage commissions or stock transfer taxes deducted from your payment. See Section 1. HOW MANY SHARES WILL UTMD PURCHASE? We would like to pu
up to 650,000 shares of its common stock, par value $.01 per share (hereinafter referred to as the "Shares"), to the Company at a price of $75.00 per Share, upon the terms and subject to the conditions set forth herein and in the related Letter of Transmittal (which together constitute the "Offer"). The Company will, upon t
eries D Preferred Stock”) five and one-half shares (5.5) shares of its Series A Common Stock, par value $0.01 per share (“Common Stock”), to be newly issued by Presidio, upon the terms and subject to the conditions set forth in the prospectus dated September 2, 2026 (the “Prospectus”) (which, together with any
you will be entitled to receive $53.00 in cash, without interest thereon and less any required tax withholdings, for each share of MarineMax common stock
Agreement and Plan of Merger, dated as of August 9, 2026
described in the attached proxy statement and the Merger Agreement) will be canceled and automatically converted into the right to receive $14.25 per share in cash, without interest thereon, subject to any required tax withholding in accordance with the terms of the Merger Agreement. The Merger Consideration represents a pr
Agreement and Plan of Merger, dated as of July 20, 2026